Milton, Mark N.

The TeGenero Incident and the Duff Report Conclusions: A Series of Unfortunate Events or an Avoidable Event?

Horvath, C. J., & Milton, M. N. (2009) · Toxicologic Pathology

Pharmacovigilance and Adverse Drug ReactionsEthics in Clinical Research

Cited by 87

Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays

Gorovits, B., Fiscella, M., Havert, M., Koren, E., Long, B., Milton, M., & Purushothama, S. (2020) · The AAPS Journal

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 57

Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays

Gorovits, B., Azadeh, M., Buchlis, G., Harrison, T., Havert, M., Jawa, V., Long, B., McNally, J., Milton, M., Nelson, R., et al. (2021) · The AAPS Journal

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 53

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

Cummings, B. B., Joing, M. P., Bouchard, P. R., Milton, M. N., Moesta, P. F., Ramanan, V., Lane, A., Hirman, J., Trauger, J. W., Maratos-Flier, E., et al. (2025) · The Lancet

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 49

Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa

MacLachlan, T. K., Milton, M. N., Turner, O., Tukov, F., Choi, V. W., Penraat, J., Hanks, S. M., Vrouvlianis, J., Leehy, B., Li, H., et al. (2018) · Molecular Therapy - Methods & Clinical Development

Retinal Development and DisordersVirus-based gene therapy research

Cited by 40